Bionano Genomics, Inc. - Common Stock, par value $0.0001 per share (BNGO)

CUSIP: 09075F305

Q2 2024 13F Holders as of 30 Jun 2024

Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
138,961,039
Total 13F shares
6,607,426
Share change
+1,939,010
Total reported value
$4,480,183
Put/Call ratio
59%
Price per share
$0.68
Number of holders
52
Value change
+$918,263
Number of buys
25
Number of sells
31

Sponsored

Quarterly Holders Quick Answers

What is CUSIP 09075F305?
CUSIP 09075F305 identifies BNGO - Bionano Genomics, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of BNGO - Bionano Genomics, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
Soheil Shams
3/4/5
Chief Informatics Officer
mixed-class rows
5,556,479
mixed-class rows
$3,217,163 15 Feb 2022
VANGUARD GROUP INC
13F
Company
1.4%
1,894,761
$2,103,184 31 Mar 2024
13F
GSA CAPITAL PARTNERS LLP
13F
Company
0.4%
549,789
$610,000 31 Mar 2024
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.29%
401,380
$445,633 31 Mar 2024
13F
BlackRock Finance, Inc.
13F
Company
0.28%
385,350
$427,739 31 Mar 2024
13F
CITADEL ADVISORS LLC
13F
Company
0.17%
240,215
$266,639 31 Mar 2024
13F
Christopher P. Stewart
3/4/5
Chief Financial Officer
class O/S missing
281,373
$180,810 12 May 2023
JANE STREET GROUP, LLC
13F
Company
0.11%
157,823
$175,184 31 Mar 2024
13F
Cetera Investment Advisers
13F
Company
0.11%
147,651
$163,893 31 Mar 2024
13F
STATE STREET CORP
13F
Company
0.08%
113,988
$126,527 31 Mar 2024
13F
NORTHERN TRUST CORP
13F
Company
0.08%
107,155
$118,942 31 Mar 2024
13F
XTX Topco Ltd
13F
Company
0.07%
96,847
$107,500 31 Mar 2024
13F
Quadrature Capital Ltd
13F
Company
0.06%
88,326
$97,159 31 Mar 2024
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
0.05%
75,449
$83,748 31 Mar 2024
13F
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
0.05%
70,370
$79,000 31 Mar 2024
13F
Archford Capital Strategies, LLC
13F
Company
0.05%
69,564
$77,216 31 Mar 2024
13F
OSAIC HOLDINGS, INC.
13F
Company
0.04%
60,130
$66,739 31 Mar 2024
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
0.04%
49,333
$54,760 31 Mar 2024
13F
MORGAN STANLEY
13F
Company
0.03%
44,841
$49,774 31 Mar 2024
13F
TWO SIGMA SECURITIES, LLC
13F
Company
0.03%
35,656
$39,578 31 Mar 2024
13F
Inspire Advisors, LLC
13F
Company
0.02%
34,627
$38,436 31 Mar 2024
13F
Virtu Financial LLC
13F
Company
0.02%
32,883
$36,000 31 Mar 2024
13F
STIFEL FINANCIAL CORP
13F
Company
0.02%
31,418
$34,874 31 Mar 2024
13F
CARRET ASSET MANAGEMENT, LLC
13F
Company
0.02%
28,500
$31,635 31 Mar 2024
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.02%
27,990
$31,069 31 Mar 2024
13F
HRT FINANCIAL LP
13F
Company
0.02%
20,985
$23,000 31 Mar 2024
13F
Squarepoint Ops LLC
13F
Company
0.01%
20,181
$22,401 31 Mar 2024
13F
Raymond James Financial Services Advisors, Inc.
13F
Company
0.01%
18,503
$20,538 31 Mar 2024
13F
Gulsen Kama
3/4/5
Chief Financial Officer
mixed-class rows
91,000
mixed-class rows
$20,320 03 Jun 2024
TWO SIGMA ADVISERS, LP
13F
Company
0.01%
17,000
$18,870 31 Mar 2024
13F
Point72 Asia (Singapore) Pte. Ltd.
13F
Company
0.01%
14,533
$16,132 31 Mar 2024
13F
Atom Investors LP
13F
Company
0.01%
14,355
$15,934 31 Mar 2024
13F
SIMPLEX TRADING, LLC
13F
Company
0.01%
13,643
$15,000 31 Mar 2024
13F
DLK Investment Management, LLC
13F
Company
0.01%
12,350
$13,709 31 Mar 2024
13F
UBS Group AG
13F
Company
0.01%
8,560
$9,501 31 Mar 2024
13F
CITIGROUP INC
13F
Company
0.01%
7,028
$7,801 31 Mar 2024
13F
FMR LLC
13F
Company
0%
3,239
$3,595 31 Mar 2024
13F
Federation Des Caisses Desjardins du Quebec
13F
Individual
0%
3,226
$3,581 31 Mar 2024
13F
BANK OF AMERICA CORP /DE/
13F
Company
0%
1,778
$1,973 31 Mar 2024
13F
WELLS FARGO & COMPANY/MN
13F
Company
0%
1,692
$1,878 31 Mar 2024
13F
CONCOURSE FINANCIAL GROUP SECURITIES, INC.
13F
Company
0%
1,300
$1,443 31 Mar 2024
13F
RHUMBLINE ADVISERS
13F
Company
0%
1,228
$1,363 31 Mar 2024
13F
JPMORGAN CHASE & CO
13F
Company
0%
770
$855 31 Mar 2024
13F
Tower Research Capital LLC (TRC)
13F
Company
0%
664
$737 31 Mar 2024
13F
Retirement Group, LLC
13F
Company
0%
600
$666 31 Mar 2024
13F
AllSquare Wealth Management LLC
13F
Company
0%
200
$222 31 Mar 2024
13F
BARCLAYS PLC
13F
Company
0%
200
$222 31 Mar 2024
13F
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO
13F
Company
0%
131
$145 31 Mar 2024
13F
PNC FINANCIAL SERVICES GROUP, INC.
13F
Company
0%
127
$141 31 Mar 2024
13F
Qube Research & Technologies Ltd
13F
Company
0%
113
$125 31 Mar 2024
13F

Institutional Holders of Bionano Genomics, Inc. - Common Stock, par value $0.0001 per share (BNGO) as of Q2 2024

As of 30 Jun 2024, Bionano Genomics, Inc. - Common Stock, par value $0.0001 per share (BNGO) was held by 52 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 6,607,426 shares. The largest 10 holders included VANGUARD GROUP INC, ARMISTICE CAPITAL, LLC, BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, GMT CAPITAL CORP, Cetera Investment Advisers, NORTHERN TRUST CORP, STATE STREET CORP, PRICE T ROWE ASSOCIATES INC /MD/, and Archford Capital Strategies, LLC. This page lists 53 institutional shareholders reporting positions in this security for the Q2 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2024 vs Q1 2024 Across Filers

Q1 2024 holders
57
Q2 2024 holders
52
Holder diff
-5
Investor Q1 2024 Shares Q2 2024 Shares Share Diff Share Chg % Q1 2024 Value $ Q2 2024 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.